Skip to main content
Clinical Trials/NCT01701960
NCT01701960WithdrawnNot Applicable

Effect of Local Anesthetic on Hemodynamic Measures During Nasal Surgery

Loma Linda University1 site in 1 countryStarted: November 2012Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Withdrawn
Locations
1
Primary Endpoint
change in blood pressure

Study Overview

Brief Summary

1% Lidocaine with 1:100,000 to 1:200,000 of epinephrine is routinely injected into the nasal mucosa during nasal surgery to reduce patient blood loss and improve the surgical field and visibility. Typically 1% lidocaine with 1:100,000 of epinephrine is used in nasal surgery. However, 1 % lidocaine with 1:200,000 (which is a more dilute solution of epinephrine) is also used. This latter dose theoretically should have a lesser effect on cardiac stimulation which increases the heart rate and blood pressure at the time of surgery. The nasal mucosa has excellent absorbing ability which is great for the application of drugs but there is concern for systemic absorption and side effects. Potential serious side effects can occur with local injection such as hypertension, tachycardia, and cardiac arrhythmias. These side effects occur mainly through the absorption of epinephrine. It is the goal of this study to see if a weaker concentration of epinephrine (1:200,000) can maintain a good surgical field with a decrease in hemodynamic side effects.

Detailed Description

Objective- To evaluate the effect of 1% lidocaine with 1:200,000 of epinephrine on hemodynamic measures and bleeding in the surgical field in patients undergoing nasal surgery compared to 1% lidocaine with 1:100,000.

Recruitment plan- Patients undergoing general anesthetic for nasal surgery (septoplasty or sinus surgery) will be asked to participate in this study. All patients undergoing nasal surgery are injected with local anesthetic into the nasal mucosa after induction of general anesthetic. Those patients who agree to participate in the study will be randomized into 2 groups (injection either 1 % lidocaine with 1:100,000 or 1:200,000 of epinephrine).

Procedures

  1. Patients will be put to sleep following standard general anesthetic protocol

  2. Patients will be injected with either 1% lidocaine with 1:100,000 or 1% lidocaine with 1:200,000 into the nasal mucosa

  3. After injection the following will be measured every 15 minutes for the first hour to evaluate effectiveness of the local anesthetic.

  4. Heart rate

  5. Blood pressure

  6. Routine ECG monitoring

  7. MAP (mean arterial pressure)

  8. Surgical field, degree of bleeding.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
16 Years to 75 Years (Child, Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • any patient between the ages of 16-75 who is scheduled to undergo routine nasal surgery.

Exclusion Criteria

  • allergy to lidocaine,
  • recent MI,
  • recent stroke,
  • uncontrolled hypertension,
  • arrhythmias,
  • congestive heart failure.

Outcomes

Primary Outcomes

change in blood pressure

Time Frame: over the course of surgery

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Kristin Seiberling, MD

Associate Professor

Loma Linda University

Study Sites (1)

Loading locations...

Similar Trials